Next Article in Journal
Half-Fluence, Half-Dose Photodynamic Therapy: Less Direct Damage but More Inflammation?
Next Article in Special Issue
Pharmacotherapy for Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Past, Present, and Future
Previous Article in Journal
Effects of Apocynin, a NADPH Oxidase Inhibitor, in the Protection of the Heart from Ischemia/Reperfusion Injury
Previous Article in Special Issue
Pharmacology and Emerging Therapies for Group 3 Pulmonary Hypertension Due to Chronic Lung Disease
 
 
Article

Article Versions Notes

Pharmaceuticals 2023, 16(4), 493; https://doi.org/10.3390/ph16040493
Action Date Notes Link
article xml file uploaded 27 March 2023 05:32 CEST Original file -
article xml uploaded. 27 March 2023 05:32 CEST Update https://www.mdpi.com/1424-8247/16/4/493/xml
article pdf uploaded. 27 March 2023 05:32 CEST Version of Record https://www.mdpi.com/1424-8247/16/4/493/pdf
article html file updated 27 March 2023 05:34 CEST Original file -
article html file updated 6 April 2023 22:45 CEST Update https://www.mdpi.com/1424-8247/16/4/493/html
Back to TopTop